Home Thyroid-stimulating hormone reference range and factors affecting it in a nationwide random sample
Article
Licensed
Unlicensed Requires Authentication

Thyroid-stimulating hormone reference range and factors affecting it in a nationwide random sample

  • Ville L. Langén EMAIL logo , Teemu J. Niiranen , Juhani Mäki , Jouko Sundvall and Antti M. Jula
Published/Copyright: June 20, 2014

Abstract

Background: Previous studies with mainly selected populations have proposed contradicting reference ranges for thyroid-stimulating hormone (TSH) and have disagreed on how screening, age and gender affect them. This study aimed to determine a TSH reference range on the Abbott Architect ci8200 integrated system in a large, nationwide, stratified random sample. To our knowledge this is the only study apart from the NHANES III that has addressed this issue in a similar nationwide setting. The effects of age, gender, thyroid peroxidase antibody (TPOAb)-positivity and medications on TSH reference range were also assessed.

Methods: TSH was measured from 6247 participants randomly drawn from the population register to represent the Finnish adult population. TSH reference ranges were established of a thyroid-healthy population and its subpopulations with increasing and cumulative rigour of screening: screening for overt thyroid disease (thyroid-healthy population, n=5709); screening for TPOAb-positivity (risk factor-free subpopulation, n=4586); and screening for use of any medications (reference subpopulation, n=1849).

Results: The TSH reference ranges of the thyroid-healthy population, and the risk factor-free and reference subpopulations were 0.4–4.4, 0.4–3.7 and 0.4–3.4 mU/L (2.5th–97.5th percentiles), respectively. Although the differences in TSH between subgroups for age (p=0.002) and gender (p=0.005) reached statistical significance, the TSH distribution curves of the subgroups were practically superimposed.

Conclusions: We propose 0.4–3.4 mU/L as a TSH reference range for adults for this platform, which is lower than those presently used in most laboratories. Our findings suggest that intensive screening for thyroid risk factors, especially for TPOAb-positivity, decreases the TSH upper reference limit.


Corresponding author: Ville L. Langén, MD, Population Studies Unit, National Institute for Health and Welfare, Peltolantie 3, 20720 Turku, Finland, Phone: +358 29 524 6000, E-mail:

References

1. Demers LM, Spencer CA, editors. Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease. Washington, DC: National Academy of Clinical Biochemistry, 2002.Search in Google Scholar

2. Surks MI, Boucai L. Age- and race-based serum thyrotropin reference limits. J Clin Endocrinol Metab 2010;95:496–502.10.1210/jc.2009-1845Search in Google Scholar PubMed

3. Surks MI, Hollowell JG. Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism. J Clin Endocrinol Metab 2007;92:4575–82.10.1210/jc.2007-1499Search in Google Scholar PubMed

4. Friis-Hansen L, Hilsted L. Reference intervals for thyreotropin and thyroid hormones for healthy adults based on the NOBIDA material and determined using a Modular E170. Clin Chem Lab Med 2008;46:1305–12.10.1515/CCLM.2008.258Search in Google Scholar PubMed

5. Atzmon G, Barzilai N, Hollowell JG, Surks MI, Gabriely I. Extreme longevity is associated with increased serum thyrotropin. J Clin Endocrinol Metab 2009;94:1251–4.10.1210/jc.2008-2325Search in Google Scholar PubMed PubMed Central

6. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002;87:489–99.10.1210/jcem.87.2.8182Search in Google Scholar PubMed

7. Takeda K, Mishiba M, Sugiura H, Nakajima A, Kohama M, Hiramatsu S. Evaluated reference intervals for serum free thyroxine and thyrotropin using the conventional outliner rejection test without regard to presence of thyroid antibodies and prevalence of thyroid dysfunction in Japanese subjects. Endocr J 2009;56:1059–66.10.1507/endocrj.K09E-123Search in Google Scholar PubMed

8. Schalin-Jäntti C, Tanner P, Välimäki MJ, Hämäläinen E. Serum TSH reference interval in healthy Finnish adults using the Abbott Architect 2000i Analyzer. Scand J Clin Lab Invest 2011;71:344–9.10.3109/00365513.2011.568630Search in Google Scholar PubMed

9. O’Leary PC, Feddema PH, Michelangeli VP, Leedman PJ, Chew GT, Knuiman M, et al. Investigations of thyroid hormones and antibodies based on a community health survey: the Busselton thyroid study. Clin Endocrinol (Oxf) 2006;64:97–104.10.1111/j.1365-2265.2005.02424.xSearch in Google Scholar PubMed

10. Hoogendoorn EH, Hermus AR, de Vegt F, Ross HA, Verbeek AL, Kiemeney LA, et al. Thyroid function and prevalence of anti-thyroperoxidase antibodies in a population with borderline sufficient iodine intake: influences of age and sex. Clin Chem 2006;52:104–11.10.1373/clinchem.2005.055194Search in Google Scholar PubMed

11. Waise A, Price HC. The upper limit of the reference range for thyroid-stimulating hormone should not be confused with a cut-off to define subclinical hypothyroidism. Ann Clin Biochem 2009;46:93–8.10.1258/acb.2008.008113Search in Google Scholar PubMed

12. Kratzsch J, Fiedler GM, Leichtle A, Brügel M, Buchbinder S, Otto L, et al. New reference intervals for thyrotropin and thyroid hormones based on National Academy of Clinical Biochemistry criteria and regular ultrasonography of the thyroid. Clin Chem 2005;51:1480–6.10.1373/clinchem.2004.047399Search in Google Scholar

13. Zöphel K, Wunderlich G, Grüning T, Koch R, Döge H, Kotzerke J. Where does subclinical hypothyroidism start? Implications for the definition of the upper reference limit for thyroid stimulating hormone. Nuklearmedizin 2005;44:56–61.10.1055/s-0038-1623926Search in Google Scholar

14. Zöphel K, Wunderlich G, Kotzerke J. Should we really determine a reference population for the definition of thyroid-stimulating hormone reference interval? Clin Chem 2006;52:329–30.10.1373/clinchem.2005.060111Search in Google Scholar

15. Laiho J, Djerf K, Lehtonen R. Sampling design. In: Heistaro S, editor. Methodology report, Health 2000 Survey. Helsinki: National Public Health Institute, 2008:13–5. Available from: http://www.terveys2000.fi/doc/methodologyrep.pdf. Accessed on 7 June, 2014.Search in Google Scholar

16. O’Leary PC, Boyne P, Atkinson G, Mileham KJ, James I. Longitudinal study of serum thyroid hormone levels during normal pregnancy. Int J Gynaecol Obstet 1992;38:171–9.10.1016/0020-7292(82)90125-4Search in Google Scholar

17. Kurioka H, Takahashi K, Miyazaki K. Maternal thyroid function during pregnancy and puerperal period. Endocr J 2005;52:587–91.10.1507/endocrj.52.587Search in Google Scholar

18. Kundra P, Burman KD. The effect of medications on thyroid function tests. Med Clin North Am 2012;96:283–95.10.1016/j.mcna.2012.02.001Search in Google Scholar

19. Wiegratz I, Kutschera E, Lee JH, Moore C, Mellinger U, Winkler UH, et al. Effect of four oral contraceptives on thyroid hormones, adrenal and blood pressure parameters. Contraception 2003;67:361–6.10.1016/S0010-7824(03)00006-4Search in Google Scholar

20. Bjoro T, Holmen J, Krüger O, Midthjell K, Hunstad K, Schreiner T, et al. Prevalence of thyroid disease, thyroid dysfunction and thyroid peroxidase antibodies in a large, unselected population. The Health Study of Nord-Trondelag (HUNT). Eur J Endocrinol 2000;143:639–47.10.1530/eje.0.1430639Search in Google Scholar PubMed

21. Guan H, Shan Z, Teng X, Li Y, Teng D, Jin Y, et al. Influence of iodine on the reference interval of TSH and the optimal interval of TSH: results of a follow-up study in areas with different iodine intakes. Clin Endocrinol (Oxf) 2008;69:136–41.10.1111/j.1365-2265.2007.03150.xSearch in Google Scholar PubMed

22. Spencer CA, Takeuchi M, Kazarosyan M, MacKenzie F, Beckett GJ, Wilkinson E. Interlaboratory/intermethod differences in functional sensitivity of immunometric assays of thyrotropin (TSH) and impact on reliability of measurement of subnormal concentrations of TSH. Clin Chem 1995;41:367–74.10.1093/clinchem/41.3.367Search in Google Scholar

23. Chan AO, Iu YP, Shek CC. The reference interval of thyroid-stimulating hormone in Hong Kong Chinese. J Clin Pathol 2011;64:433–6.10.1136/jcp.2010.087627Search in Google Scholar PubMed

24. Eskelinen S, Suominen P, Vahlberg T, Löppönen M, Isoaho R, Kivelä SL, et al. The effect of thyroid antibody positivity on reference intervals for thyroid stimulating hormone (TSH) and free thyroxine (FT4) in an aged population. Clin Chem Lab Med 2005;43:1380–5.10.1515/CCLM.2005.236Search in Google Scholar PubMed

25. Jensen E, Hyltoft Petersen P, Blaabjerg O, Hansen PS, Brix TH, Kyvik KO, et al. Establishment of a serum thyroid stimulating hormone (TSH) reference interval in healthy adults. The importance of environmental factors, including thyroid antibodies. Clin Chem Lab Med 2004;42:824–32.Search in Google Scholar

26. Surks MI. TSH reference limits: new concepts and implications for diagnosis of subclinical hypothyroidism. Endocr Pract 2013;19:1066–9.10.4158/EP13246.COSearch in Google Scholar PubMed

27. Statistical Yearbook of Finland 2012. Helsinki: Statistics Finland, 2012:97. Available from: http://www.stat.fi/tup/julkaisut/tiedostot/julkaisuluettelo/yyti_stv_201200_2012_6270_net.pdf. Accessed on 7 June, 2014.Search in Google Scholar

28. Varo P, Saari E, Paaso A, Koivistoinen P. Iodine in Finnish foods. Int J Vitam Nutr Res 1982;52:80–9.Search in Google Scholar

29. Lamberg BA, Haikonen M, Mäkelä M, Jukkara A, Axelson E, Welin MG. Further decrease in thyroidal uptake and disappearance of endemic goitre in children after 30 years of iodine prophylaxis in the east of Finland. Acta Endocrinol (Copenh) 1981;98:205–9.10.1530/acta.0.0980205Search in Google Scholar PubMed

30. Bülow Pedersen I, Laurberg P, Knudsen N, Jørgensen T, Perrild H, Ovesen L, et al. A population study of the association between thyroid autoantibodies in serum and abnormalities in thyroid function and structure. Clin Endocrinol (Oxf) 2005;62:713–20.10.1111/j.1365-2265.2005.02284.xSearch in Google Scholar PubMed


Supplemental Material

The online version of this article (DOI 10.1515/cclm-2014-0287) offers supplementary material, available to authorized users.


Received: 2014-3-14
Accepted: 2014-5-19
Published Online: 2014-6-20
Published in Print: 2014-12-1

©2014 by De Gruyter

Articles in the same Issue

  1. Frontmatter
  2. Editorials
  3. CCLM Award for The Most Cited Paper Recently Published
  4. Laboratory preparedness to face infectious outbreaks. Ebola and beyond
  5. Reviews
  6. Determination of reference limits: statistical concepts and tools for sample size calculation
  7. Recent advances in physiological lipoprotein metabolism
  8. New laboratory markers for the management of rheumatoid arthritis patients
  9. General Clinical Chemistry and Laboratory Medicine
  10. The impact of repeat-testing of common chemistry analytes at critical concentrations
  11. Performance of CKD-EPI equation to estimate glomerular filtration rate as compared to MDRD equation in South Brazilian individuals in each stage of renal function
  12. The serum uromodulin level is associated with kidney function
  13. Efficient assessment of peripheral blood lymphocytosis in adults: developing new thresholds for blood smear review by pathologists
  14. Performance evaluation of Sysmex XN hematology analyzer in umbilical cord blood: a comparison study with Sysmex XE-2100
  15. UF-1000i: validation of the body fluid mode for counting cells in body fluids
  16. Newborn screening for haemoglobinopathies by high performance liquid chromatography (HPLC): diagnostic utility of different approaches in resource-poor settings
  17. Progressive chromogenic anti-factor Xa assay and its use in the classification of antithrombin deficiencies
  18. Reference Values and Biological Variations
  19. Thyroid-stimulating hormone reference range and factors affecting it in a nationwide random sample
  20. Reference ranges for serum β-trace protein in neonates and children younger than 1 year of age
  21. A multicenter nationwide reference intervals study for common biochemical analytes in Turkey using Abbott analyzers
  22. Serum reference intervals of homoarginine, ADMA, and SDMA in the Study of Health in Pomerania
  23. Cancer Diagnostics
  24. Low SOX17 expression: prognostic significance in de novo acute myeloid leukemia with normal cytogenetics
  25. Results of first proficiency test for KRAS testing with formalin-fixed, paraffin-embedded cell lines in China
  26. Aberrant hypermethylation of CTNNA1 gene is associated with higher IPSS risk in patients with myelodysplastic syndrome
  27. Cardiovascular Diseases
  28. Association between SNP rs13376333 and rs1131820 in the KCNN3 gene and atrial fibrillation in the Chinese Han population
  29. Acknowledgment
  30. Acknowledgment
  31. Letters to the Editor
  32. Interference in thyroid hormones with Roche immunoassays: an unfinished story
  33. Discrepant results in plasma, but not serum in the Beckman Coulter DxI Access HYPERsensitive hTSH 3rd generation assay affect the management of differentiated thyroid cancer and hyperthyroid patients
  34. Improper serum separation on gel tubes: a trivial laboratory problem or an indicator of monoclonal gammopathy?
  35. Analytical comparison of the new point-of-care troponin T immunoassay on AQT90Flex® analyzer (Radiometer) and the high-sensitivity troponin T immunoassay on ModularE170® (Roche Diagnostics)
  36. Performance characteristics of the enzymatic Abbott Architect HbA1c whole blood assay
  37. Multi-center proficiency tests for Lab-MELD score diagnostics to improve the quality and safety for patients awaiting liver transplantation
  38. The apolipoprotein B/apolipoprotein A-I ratio in healthy men with normolipidemia: limits of variation and relationship with other lipid parameters
  39. Validity and reliability of the 13C-methionine breath test for the detection of moderate hyperhomocysteinemia in Mexican adults; statistical issues in validity and reliability analysis
  40. Enzymatic and endpoint methods yield comparable adenosine deaminase activity in pleural fluid samples
  41. Congress Abstract
  42. 5th Italian GREAT Network Congress
  43. Congress of Laboratory Medicine and Clinical Chemistry
Downloaded on 2.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2014-0287/html
Scroll to top button